Alcohol Use and Breast Cancer: A Critical Review

Alcoholism: Clinical and Experimental Research

Volumn 40, Issue 6, 2016, Pages 1166-1181

  Shield, Kevin D ^a   Soerjomataram, Isabelle ^a   Rehm, Jürgen ^b,c,d  

^a INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^b CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

Author keywords

Alcohol; Breast cancer; Incidence; Mortality; Systematic review

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); ALCOHOL DEHYDROGENASE; ANDROSTENEDIONE; CYTOCHROME P450 2E1; ESTROGEN; ESTROGEN RECEPTOR; PRASTERONE SULFATE; REACTIVE OXYGEN METABOLITE; RESVERATROL; SOMATOMEDIN; TESTOSTERONE;

ALCOHOL CONSUMPTION; ALCOHOL METABOLISM; BREAST CANCER; BREAST CARCINOGENESIS; BREAST DENSITY; CANCER INCIDENCE; CANCER MORTALITY; CANCER RISK; CARBON METABOLISM; FOLATE METABOLISM; GENE MUTATION; HUMAN; MALE BREAST CANCER; NONHUMAN; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; BREAST TUMOR; DRINKING BEHAVIOR; INCIDENCE; META ANALYSIS; MORTALITY; RISK FACTOR;

ALCOHOL DRINKING; BREAST NEOPLASMS; HUMANS; INCIDENCE; RISK FACTORS;

EID: 84971477336     PISSN: 01456008     EISSN: 15300277     Source Type: Journal    
DOI: 10.1111/acer.13071     Document Type: Review

References (154)

1. Ali AM, Schmidt MK, Bolla MK, Wang Q, Gago-Dominguez M, Castelao JE, Carracedo A, Garzon VM, Bojesen SE, Nordestgaard BG, Flyger H, Chang-Claude J, Vrieling A, Rudolph A, Seibold P, Nevanlinna H, Muranen TA, Aaltonen K, Blomqvist C, Matsuo K, Ito H, Iwata H, Horio A, John EM, Sherman M, Lissowska J, Figueroa J, Garcia-Closas M, Anton-Culver H, Shah M, Hopper JL, Trichopoulou A, Bueno-de-Mesquita B, Krogh V, Weiderpass E, Andersson A, Clavel-Chapelon F, Dossus L, Fagherazzi G, Peeters PH, Olsen A, Wishart GC, Easton DF, Borgquist S, Overvad K, Barricarte A, González CA, Sánchez MJ, Amiano P, Riboli E, Key T, Pharoah PD (2014) Alcohol consumption and survival after a breast cancer diagnosis: a literature-based meta-analysis and collaborative analysis of data for 29, 239 cases. Cancer Epidemiol Biomark Prev 23:934-945.
2. Allen NE, Beral V, Casabonne D, Kan SW, Reeves GK, Brown A, Green J (2009) Moderate alcohol intake and cancer incidence in women. J Natl Cancer Inst 101:296-305.
3. Ames BN (1983) Dietary carcinogens and anticarcinogens. Oxygen radicals and degenerative diseases. Science 221:1256-1264.
4. Anderson P, Chisholm D, Fuhr D (2009) Effectiveness and cost-effectiveness of policies and programmes to reduce the harm caused by alcohol. Lancet 373:2234-2246.
5. Baan R, Straif K, Grosse Y, Secretan B, El Ghissassi F, Bouvard V, Alteri A, Cogliano V; WHO International Agency for Research on Cancer Monograph Working Group (2007) Carcinogenicity of alcoholic beverages. Lancet Oncol 8:292-293.
6. Bagnardi V, Blangiardo M, La Vecchia C, Corrao G (2001a) Alcohol consumption and the risk of cancer: a meta-analysis. Alcohol Res Health 25:263-270.
7. Bagnardi V, Blangiardo M, La Vecchia C, Corrao G (2001b) A meta-analysis of alcohol drinking and cancer risk. Br J Cancer 85:1700-1705.
8. Bagnardi V, Rota M, Botteri E, Tramacere I, Islami F, Fedirko V, Scotti L, Jenab M, Turati F, Pasquali E, Pelucchi C, Bellocco R, Negri E, Corrao G, Rehm J, Boffetta P, La Vecchia C (2013) Light alcohol drinking and cancer: a meta-analysis. Ann Oncol 24:301-308.
9. Bagnardi V, Rota M, Botteri E, Tramacere I, Islami F, Fedirko V, Scotti L, Jenab M, Turati F, Pasquali E, Pelucchi C, Galeone C, Bellocco R, Negri E, Corrao G, Boffetta P, La Vecchia C (2015) Alcohol consumption and site-specific cancer risk: a comprehensive dose-response meta-analysis. Br J Cancer 112:580-593.
10. Baur JA, Mai A (2012) Revelations into resveratrol's mechanism. Nat Med 18:500-501.
11. Boffetta P, Hashibe M (2006) Alcohol and cancer. Lancet Oncol 7:149-156.
12. Bosoi CR, Rose CF (2013) Oxidative stress: a systemic factor implicated in the pathogenesis of hepatic encephalopathy. Metab Brain Dis 28:175-178.
13. Bosron WF, Li TK (1986) Genetic polymorphism of human liver alcohol and aldehyde dehydrogenases, and their relationship to alcohol metabolism and alcoholism. Hepatology 6:502-510.
14. Boyd NF, Rommens JM, Vogt K, Lee V, Hopper JL, Yaffe MJ, Paterson AD (2005) Mammographic breast density as an intermediate phenotype for breast cancer. Lancet Oncol 6:798-808.
15. Bray F, Jemal A, Grey N, Ferlay J, Forman D (2012) Global cancer transitions according to the Human Development Index (2008-2030): a population-based study. Lancet Oncol 13:790-801.
16. Bray F, McCarron P, Parkin DM (2004) The changing global patterns of female breast cancer incidence and mortality. Breast Cancer Res 6:229-239.
17. Brennan SF, Cantwell MM, Cardwell CR, Velentzis LS, Woodside JV (2010) Dietary patterns and breast cancer risk: a systematic review and meta-analysis. Am J Clin Nutr 91:1294-1302.
18. Cao Y, Willett WC, Rimm EB, Stampfer MJ, Giovannucci EL (2015) Light to moderate intake of alcohol, drinking patterns and risk of cancer: results from two prospective US cohort studies. BMJ 351:h4238.
19. Castro GD, Delgado de Layño AMA, Fanelli SL, Maciel ME, Díaz Gómez MI, Castro JA (2008) Acetaldehyde accumulation in rat mammary tissue after an acute treatment with alcohol. J Appl Toxicol 28:315-321.
20. Cauley JA, Lucas FL, Kuller LH, Stone K, Browner W, Cummings SR (1999) Elevated serum estradiol and testosterone concentrations are associated with a high risk for breast cancer. Ann Intern Med 130:270-277.
21. Chen WY, Rosner B, Hankinson SE, Colditz GA, Willett WC (2011) Moderate alcohol consumption during adult life, drinking patterns, and breast cancer risk. JAMA 306:1884-1890.
22. Choi JY, Abel J, Neuhaus T, Ko Y, Harth V, Hamajima N, Tajima K, Yoo KY, Park SK, Noh DY, Han W, Choe KJ, Ahn SH, Kim SU, Hirvonen A, Kang D (2003) Role of alcohol and genetic polymorphisms of CYP2E1 and ALDH2 in breast cancer development. Pharmacogenetics 13:67-72.
23. Choi SW, Frisco S (2005) Interactions between folate and aging for carcinogenesis. Clin Chem Lab Med 43:1151-1157.
24. Chu KC, Tarone RE, Kessler LG, Ries LA, Hankey BF, Miller BA, Edwards BK (1996) Recent trends in US breast cancer incidence, survival, and mortality rates. J Natl Cancer Inst 88:1571-1579.
25. Chung FL, Chen HJC, Nath RG (1996) Lipid peroxidation as a potential endogenous source for the formation of exocyclic DNA adducts. Carcinogenesis 17:2105-2111.
26. Colditz GA (2005) Epidemiology and prevention of breast cancer. Cancer Epidemiol Biomark Prev 14:768-772.
27. Colditz GA, Frazier AL (1995) Models of breast cancer show that risk is set by events of early life: prevention efforts must shift focus. Cancer Epidemiol Biomark Prev 4:567-571.
28. Cook MB, Guénel P, Gapstur SM, van den Brandt PA, Michels KB, Casagrande JT, Cooke R, Van Den Eeden SK, Ewertz M, Falk RT, Gaudet MM, Gkiokas G, Habel LA, Hsing AW, Johnson K, Kolonel LN, La Vecchia C, Lynge E, Lubin JH, McCormack VA, Negri E, Olsson H, Parisi D, Petridou ET, Riboli E, Sesso HD, Swerdlow A, Thomas DB, Willett WC, Brinton LA (2015) Tobacco and alcohol in relation to male breast cancer: an analysis of the male breast cancer pooling project consortium. Cancer Epidemiol Biomark Prev 24:520-531.
29. Corrao G, Bagnardi V, Zambon A, La Vecchia C (2004) A meta-analysis of alcohol consumption and the risk of 15 diseases. Prev Med 38:613-619.
30. Crabb DW, Edenberg HJ, Bosron WF, Li TK (1989) Genotypes for aldehyde dehydrogenase deficiency and alcohol sensitivity: the inactive ALDH2*2 allele is dominant. J Clin Invest 83:314-316.
31. De Angelis R, Sant M, Coleman MP, Francisci S, Baili P, Pierannunzio D, Trama A, Visser O, Brenner H, Ardanaz E, Bielska-Lasota M, Engholm G, Nennecke A, Siesling S, Berrino F, Capocaccia R (2014) Cancer survival in Europe 1999-2007 by country and age: results of EUROCARE-5-a population-based study. Lancet Oncol 15:23-34.
32. Doll R, Payne WJAH (1966) Cancer Incidence in Five Continents. Union Internationale Contre le Cancer, Geneva, Switzerland.
33. Dorgan JF, Baer DJ, Albert PS, Judd JT, Brown ED, Corle DK, Campbell WS, Hartman TJ, Tejpar AA, Clevidence BA, Giffen CA, Chandler DW, Stanczyk FZ, Taylor PR (2001) Serum hormones and the alcohol-breast cancer association in postmenopausal women. J Natl Cancer Inst 93:710-715.
34. Ellison R, Zhang Y, McLennan C, Rothman K (2001) Exploring the relation of alcohol consumption to risk of breast cancer. Am J Epidemiol 154:740-747.
35. Endogenous Hormones and Breast Cancer Collaborative Group, Key TJ, Appleby PN, Reeves GK, Roddam AW (2010) Insulin-like growth factor 1 (IGF1), IGF binding protein 3 (IGFBP3), and breast cancer risk: pooled individual data analysis of 17 prospective studies. Lancet Oncol 11:530-542.
36. Etique N, Chardard D, Chesnel A, Merlin JL, Flament S, Grillier-Vuissoz I (2004) Ethanol stimulates proliferation, ERalpha and aromatase expression in MCF-7 human breast cancer cells. Int J Mol Med 13:149-155.
37. Ezzati M, Vander Hoorn S, Rodgers A, Lopez AD, Mathers CD (2003) Estimates of global and regional potential health gains from reducing multiple major risk factors. Lancet 362:271-280.
38. Fagherazzi G, Vilier A, Boutron-Ruault MC, Mesrine S, Clavel-Chapelon F (2015) Alcohol consumption and breast cancer risk subtypes in the E3N-EPIC cohort. Eur J Cancer Prev 24:209-214.
39. Fan S, Meng Q, Gao B, Grossman J, Yadegari M, Goldberg ID, Rosen EM (2000) Alcohol stimulates estrogen receptor signaling in human breast cancer cell lines. Cancer Res 60:5635-5639.
40. Fanelli SL, Maciel ME, Díaz Gómez MI, delgado de Layño AMA, Bietto FM, Castro JA, Castro GD (2011) Further studies on the potential contribution of acetaldehyde accumulation and oxidative stress in rat mammary tissue in the alcohol drinking promotion of breast cancer. J Appl Toxicol 31:11-19.
41. Feinglass J, Rydzewski N, Yang A (2015) The socioeconomic gradient in all-cause mortality for women with breast cancer: findings from the 1998 to 2006 National Cancer Data Base with follow-up through 2011. Ann Epidemiol 25:549-555.
42. Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F (2013) GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11. International Agency for Research on Cancer, Lyon, France.
43. Fernandez SV, Russo J (2010) Estrogen and xenoestrogens in breast cancer. Toxicol Pathol 38:110-122.
44. Ferrari P, Janab M, Norat T, Moskal A, Slimani N, Olsen A, Tjonneland A, Overvad K, Jensen MK, Boutron-Ruault MC, Clavel-Chapelon F, Morois S, Rohrmann S, Linseisen J, Boeing H, Bergmann M, Kontopoulou D, Trichopoulou A, Kassapa C, Masala G, Krogh V, Vineis P, Panico S, Tumino R, van Gils CH, Peeters P, Bueno-de-Mesquita HB, Ocké MC, Skeie G, Lund E, Agudo A, Ardanaz E, López DC, Sanchez MJ, Quirós JR, Amiano P, Berglund G, Manjer J, Palmqvist R, Van Guelpen B, Allen N, Key T, Bingham S, Manzuir M, Boffetta P, Kaaks R, Riboli E (2007) Lifetime and baseline alcohol intake and risk of colon and rectal cancers in the European prospective investigation into cancer and nutrition (EPIC). Int J Cancer 121:2065-2072.
45. Forouzanfar MH, Alexander L, Anderson HR, Bachman VF, Biryukov S, Brauer M, Burnett R, Casey D, Coates MM, Cohen A, Delwiche K, Estep K, Frostad JJ, Astha KC, Kyu HH, Moradi-Lakeh M, Ng M, Slepak EL, Thomas BA, Wagner J, Aasvang GM, Abbafati C, Abbasoglu Ozgoren A, Abd-Allah F, Abera SF, Aboyans V, Abraham B, Abraham JP, Abubakar I, Abu-Rmeileh NM, Aburto TC, Achoki T, Adelekan A, Adofo K, Adou AK, Adsuar JC, Afshin A, Agardh EE, Al Khabouri MJ, Al Lami FH, Alam SS, Alasfoor D, Albittar MI, Alegretti MA, Aleman AV, Alemu ZA, Alfonso-Cristancho R, Alhabib S, Ali R, Ali MK, Alla F, Allebeck P, Allen PJ, Alsharif U, Alvarez E, Alvis-Guzman N, Amankwaa AA, Amare AT, Ameh EA, Ameli O, Amini H, Ammar W, Anderson BO, Antonio CA, Anwari P, Argeseanu Cunningham S, Arnlov J, Arsenijevic VS, Artaman A, Asghar RJ, Assadi R, Atkins LS, Atkinson C, Avila MA, Awuah B, Badawi A, Bahit MC, Bakfalouni T, Balakrishnan K, Balalla S, Balu RK, Banerjee A, Barber RM, Barker-Collo SL, Barquera S, Barregard L, Barrero LH, Barrientos-Gutierrez T, Basto-Abreu AC, Basu A, Basu S, Basulaiman MO, Batis Ruvalcaba C, Beardsley J, Bedi N, Bekele T, Bell ML, Benjet C, Bennett DA et al. (2015) Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 386:2287-2323.
46. Francisco DC, Peddi P, Hair JM, Flood BA, Cecil AM, Kalogerinis PT, Sigounas G, Georgakilas AG (2008) Induction and processing of complex DNA damage in human breast cancer cells MCF-7 and nonmalignant MCF-10A cells. Free Radic Biol Med 44:558-569.
47. Fruehauf JP, Meyskens FL (2007) Reactive oxygen species: a breath of life or death? Clin Cancer Res 13:789-794.
48. Gao Y, Huang YB, Liu XO, Chen C, Dai HJ, Song FJ, Wang J, Chen KX, Wang YG (2013) Tea consumption, alcohol drinking and physical activity associations with breast cancer risk among Chinese females: a systematic review and meta-analysis. Asian Pac J Cancer Prev 14:7543-7550.
49. García-Closas M, Herbstman J, Schiffman M, Glass A, Dorgan JF (2002) Relationship between serum hormone concentrations, reproductive history, alcohol consumption and genetic polymorphisms in pre-menopausal women. Int J Cancer 102:172-178.
50. Gavaler JS, Thiel DH (1992) The association between moderate alcoholic beverage consumption and serum estradiol and testosterone levels in normal postmenopausal women: relationship to the literature. Alcohol Clin Exp Res 16:87-92.
51. Giovannucci E, Chen J, Smith-Warner SA, Rimm EB, Fuchs CS, Palomeque C, Willett WC, Hunter DJ (2003) Methylenetetrahydrofolate reductase, alcohol dehydrogenase, diet, and risk of colorectal adenomas. Cancer Epidemiol Biomark Prev 12:970-979.
52. Goodman-Gruen D, Barrett-Connor E (1997) Epidemiology of insulin like growth factor-I in elderly men and women. The Rancho Bernardo Study. Am J Epidemiol 145:970-976.
53. Gou YJ, Xie DX, Yang KH, Liu YL, Zhang JH, Li B, He XD (2013) Alcohol consumption and breast cancer survival: a meta- analysis of cohort studies. Asian Pac J Cancer Prev 14:4785-4790.
54. Gouillon Z, Lucas D, Li J, Hagbjork AL, French BA, Fu P, Fang C, Ingelman-Sundberg M, Donohue TMJ, French SW (2000) Inhibition of ethanol-induced liver disease in the intragastric feeding rat model by chlormethiazole. Proc Soc Exp Biol Med 224:302-308.
55. Halsted CH, Villanueva JA, Devlin AM, Chandler CJ (2002) Metabolic interactions of alcohol and folate. J Nutr 132:2367S-2372S.
56. Hamajima N, Hirose K, Tajima K, Rohan T, Calle E, Heath C, Coates RJ, Liff JM, Talamini R, Chantarakul N, Koetsawang S, Rachawat D, Morabia A, Schuman L, Stewart W, Szklo M, Bain C, Schofield F, Siskind V, Band P, Coldman Aj, Gallagher RP, Hislop TG, Yang P, Kolonel LM, Nomura AM, Hu J, Johnson KC, Mao Y, De Sanjose S, Lee N, Marchbanks P, Ory HW, Peterson HB, Wilson HG, Wingo PA, Ebeling K, Kunde D, Nishan P, Hopper JL, Colditz G, Gajalanski V, Martin N, Pardthaisong T, Silpisornkosol S, Theetranont C, Boosiri B, Chutivongse S, Jimakorn P, Virutamasen P, Wongsrichanalai C, Ewertz M, Adami HO, Bergkvist L, Magnusson C, Persson I, Chang-Claude J, Paul C, Skegg DC, Spears GF, Boyle P, Evstifeeva T, Daling JR, Hutchinson WB, Malone K, Noonan EA, Stanford JL, Thomas DB, Weiss NS, White E, Andrieu N, Bremond A, Clavel F, Aristizabel N, Cuadros A, Tryggvadottir L, Tulinius H, Bachelot A, Le ME, Peto J, Francheschi S, Lubin F, Modan B, Ron E, Wax Y, Friedman GD, Hiatt RA, Levi F, Bishop T, Kosmelj K, Primic-Zakelj M, Ravnihar B, Stare J, Beeson WL, Fraser G, Bullbrook RD, Cuzick J, Duffy SW, Fentiman IS, Hayward JL, Wang DY, McMichael AJ, McPherson K, Hanson RL, Leske MC, Mahoney MC, Nasca PC, Varma AO, Weinstein AL, Moller TR, Olsson H, Ranstam J, Goldbohn RA, van den Brandt PA, Apelo RA, Baens J, de la Cruz JR, Javier B, Lacaya LB, Ngelangel CA, La Vecchia C, Negri E, Marubini E, Ferraroni M, Gerber M, Richardson S, Segala C, Gatei D, Kenya P, Kungu A, Mati JG, Brinton LA, Hoover R, Schairer C, Spirtas R, Lee HP, Rookus MA, van Leeuwen FE, Choenberg JA, McCredie M, Gammon MD, Clarke EA, Jones L, Neil A, Vessey M, Yeates D, Appleby P, Banks E, Beral V, Bulld D, Crossley B, Goodill A, Green J, Hermon C, Key T, Langston N, Lewis C, Reeves G, Collins R, Doll R, Peto R, Mabuchi K, Preston D, Hannaford P, Kay C, Rosero-Bixby L, Gao YT, Jin F, Yuan JM, Wei HY, Yun T, Zhiheng C, Berry G, Cooper Booth J, Jelihovsky T, MacLennan R, Shearman R, Wang QS, Baines CJ, Miller AB, Wall C, Lund E, Stasberg H, Shu XO, Zheng W, Katsouyanni K, Trichopoulou A, Trichopoulos D, Dabancens A, Martinez L, Molina R, Salas O, Alexander FE, Anderson K, Folsom AR, Hulka BS, Bernstein L, Enger S, Haile RW, Paganini-Hill A, Pike MC, Ross RK, Ursin G, Yu MC, Longnecker MP, Newcomb P, Bergkvist L, Kalache A, Farley TM, Holck S, Meirik O; Collaborative Group on Hormonal Factors in Breast C (2002) Alcohol, tobacco and breast cancer-collaborative reanalysis of individual data from 53 epidemiological studies, including 58, 515 women with breast cancer and 95, 067 women without the disease. Br J Cancer 87:1234-1245.
57. Hankinson SE, Eliassen AH (2010) Circulating sex steroids and breast cancer risk in premenopausal women. Horm Cancer 1:2-10.
58. Harvey EB, Schairer C, Brinton LA, Hoover RN, Fraumeni JJF (1987) Alcohol consumption and breast cancer. J Natl Cancer Inst 78:657-661.
59. Hayashi SI, Watanabe J, Kawajiri K (1991) Genetic polymorphisms in the 5'-flanking region change transcriptional regulation of the human cytochrome P450IIE1 gene. J Biochem 110:559-565.
60. Hines LM, Hankinson SE, Smith-Warner SA, Spiegelman D, Kelsey KT, Colditz GA, Willett WC, Hunter DJ (2000) A prospective study of the effect of alcohol consumption and ADH3 genotype on plasma steroid hormone levels and breast cancer risk. Cancer Epidemiol Biomark Prev 9:1099-1105.
61. Holmberg L, Baron JA, Byers T, Wolk A, Ohlander EM, Zack M, Adami HO (1995) Alcohol intake and breast cancer risk: effect of exposure from 15 years of age. Cancer Epidemiol Biomark Prev 4:843-847.
62. Horn-Ross PL, Canchola AJ, West DW, Stewart SL, Bernstein L, Deapen D, Pinder R, Ross RK, Anton-Culver H, Peel D, Ziogas A, Reynolds P, Wright W (2004) Patterns of alcohol consumption and breast cancer risk in the California Teachers Study cohort. Cancer Epidemiol Biomark Prev 13:405-411.
63. International Agency for Research on Cancer (1988) Alcohol Drinking. World Health Organization, Lyon, France.
64. International Agency for Research on Cancer (2010) IARC Monographs on the Evaluation of Carcinogenic Risks to Humans: Alcohol Consumption and Ethyl Carbamate, Vol. 96. International Agency for Research on Cancer, Lyon, France.
65. Jayasekara H, MacInnis RJ, Room R, English DR (2015) Long-term alcohol consumption and breast, upper aero-digestive tract and colorectal cancer risk: a systematic review and meta-analysis. Alcohol Alcohol. [Epub ahead of print].
66. Jeffreys M, McKenzie F, Firestone R, Gray M, Cheng S, Moala A, Pearce N, Ellison-Loschmann L (2013) A multi-ethnic breast cancer case-control study in New Zealand: evidence of differential risk patterns. Cancer Causes Control 24:135-152.
67. Jung S, Wang M, Anderson K, Baglietto L, Bergkvist L, Bernstein L, van den Brandt PA, Brinton L, Buring JE, Heather Eliassen A, Falk R, Gapstur SM, Giles GG, Goodman G, Hoffman-Bolton J, Horn-Ross PL, Inoue M, Kolonel LN, Krogh V, Lof M, Maas P, Miller AB, Neuhouser ML, Park Y, Robien K, Rohan TE, Scarmo S, Schouten LJ, Sieri S, Stevens VL, Tsugane S, Visvanathan K, Wilkens LR, Wolk A, Weiderpass E, Willett WC, Zeleniuch-Jacquotte A, Zhang SM, Zhang X, Ziegler RG, Smith-Warner SA (2015) Alcohol consumption and breast cancer risk by estrogen receptor status: in a pooled analysis of 20 studies. Int J Epidemiol [Epub ahead of print].
68. Kawase T, Matsuo K, Hiraki A, Suzuki T, Watanabe M, Iwata H, Tanaka H, Tajima K (2009) Interaction of the effects of alcohol drinking and polymorphisms in alcohol-metabolizing enzymes on the risk of female breast cancer in Japan. J Epidemiol 19:244-250.
69. Kehoe T, Gmel G Jr, Shield K, Gmel G Sr, Rehm J (2012) Determining the best population-level alcohol consumption model and its impact on estimates of alcohol-attributable harms. Popul Health Metr 10:6.
70. Key J, Hodgson S, Omar RZ, Jensen TK, Thomson SG, Boobis AR, Davies DS, Elliott P (2006) Meta-analysis of studies of alcohol and breast cancer with consideration of the methodological issues. Cancer Causes Control 17:759-770.
71. Key TJ, Appleby PN, Reeves GK, Travis RC, Alberg AJ, Barricarte A, Berrino F, Krogh V, Sieri S, Brinton LA, Dorgan JF, Dossus L, Dowsett M, Eliassen AH, Fortner RT, Hankinson SE, Helzlsouer KJ, Hoff man-Bolton J, Comstock GW, Kaaks R, Kahle LL, Muti P, Overvad K, Peeters PH, Riboli E, Rinaldi S, Rollison DE, Stanczyk FZ, Trichopoulos D, Tworoger SS, Vineis P (2013) Sex hormones and risk of breast cancer in premenopausal women: a collaborative reanalysis of individual participant data from seven prospective studies. Lancet Oncol 14:1009-1019.
72. Kontis V, Mathers CD, Rehm J, Stevens GA, Shield KD, Bonita R, Riley LM, Poznyak V, Beaglehole R, Ezzati M (2014) Contribution of six risk factors to achieving the 25 × 25 non-communicable disease mortality reduction target: a modelling study. Lancet 384:427-437.
73. Kraft TE, Parisotto D, Schempp C, Efferth T (2009) Fighting cancer with red wine? Molecular mechanisms of resveratrol. Crit Rev Food Sci Nutr 49:782-799.
74. Kundu TK, Velayutham M, Zweier JL (2012) Aldehyde oxidase functions as a superoxide generating NADH oxidase: an important redox regulated pathway of cellular oxygen radical formation. Biochemistry 51:2930-2939.
75. Lachenmeier DW, Godelmann R, Witt B, Riedel K, Rehm J (2014) Can resveratrol in wine protect against the carcinogenicity of ethanol? A probabilistic dose-response assessment. Int J Cancer 134:144-153.
76. Lachenmeier DW, Przybylski MC, Rehm J (2012) Comparative risk assessment of carcinogens in alcoholic beverages using the margin of exposure approach. Int J Cancer 131:E995-E1003.
77. Lakhani SR, Ellis IO, Schnitt SJ, Tan PH, van de Vijver MJ (2012) WHO Classification of Tumours of the Breast WHO/IARC Classification of Tumours. 4th ed. Vol. 4. World Health Organization, Geneva, Switzerland.
78. Langcake P, Pryce RJ (1976) The production of resveratrol by Vitis vinifera and other members of the Vitaceae as a response to infection or injury. Physiol Plant Pathol 9:77-86.
79. Larsson SC, Giovannucci E, Wolk A (2007) Folate and risk of breast cancer: a meta-analysis. J Natl Cancer Inst 99:64-76.
80. Lash TL, Aschengrau A (2000) Alcohol drinking and risk of breast cancer. Breast J 6:396-399.
81. Lathrop Stern L, Mason JB, Selbub J, Choi SW (2000) Genomic DNA hypomethylation, a characteristic of most cancers, in present in peripheral leukocytes of individuals who are homozygous for the C677T polymorphism in the methylenetetra-hydrofolate reductase gene. Cancer Epidemiol Biomark Prev 9:849-853.
82. Lee KW, Lee HJ (2006) Biphasic effects of dietary antioxidants on oxidative stress-mediated carcinogenesis. Mech Ageing Dev 127:424-431.
83. Leung T, Rajendran R, Singh S, Garva R, Krstic-Demonacos M, Demonacos C (2013) Cytochrome P450 2E1 (CYP2E1) regulates the response to oxidative stress and migration of breast cancer cells. Breast Cancer Res 15:R107.
84. Lew JQ, Freedman ND, Leitzmann MF, Brinton LA, Hoover RN, Hollenbeck AR, Schatzkin A, Park Y (2009) Alcohol and risk of breast cancer by histologic type and hormone receptor status in postmenopausal women-the NIH-AARP Diet and Health Study. Am J Epidemiol 170:308-317.
85. Li Y, Yang H, Cao J (2011) Association between alcohol consumption and cancers in the Chinese population-a systematic review and meta-analysis. PLoS One 6:e18776.
86. Liang WB, Chikritzhs T (2013) The association between alcohol exposure and self-reported health status: the effect of separating former and current drinkers. PLoS One 8:2.
87. Lim SS, Vos T, Flaxman AD, Danaei G, Shibuya K, Adair-Rohani H, Amann M, Anderson HR, Andrews KG, Aryee M, Atkinson C, Bacchus LJ, Bahalim AN, Balakrishnan K, Balmes J, Barker-Collo S, Baxter A, Bell ML, Blore JD, Blyth F, Bonner C, Borges G, Bourne R, Boussinesq M, Brauer M, Brooks P, Bruce NG, Brunekreef B, Bryan-Hancock C, Bucello C, Buchbinder R, Bull F, Burnett RT, Byers TE, Calabria B, Carapetis J, Carnahan E, Chafe Z, Charlson F, Chen H, Chen JS, Cheng T-A, Child JC, Cohen A, Colson KE, Cowie BC, Darby S, Darling S, Davis A, Degenhardt L, Dentener F, Des Jarlais DC, Devries K, Dherani M, Ding EL, Dorsey ER, Driscoll T, Edmond K, Ali SE, Engell RE, Erwin PJ, Fahimi S, Falder G, Farzadfar F, Ferrari A, Finucane MM, Flaxman S, Fowkes FG, Freedman G, Freeman MK, Gakidou E, Ghosh S, Giovannucci E, Gmel G, Graham K, Grainger R, Grant B, Gunnell D, Gutierrez HR, Hall W, Hoek HW, Hogan A, Hosgood HD III, Hoy D, Hu H, Hubbell BJ, Hutchings SJ, Ibeanusi SE, Jacklyn GL, Jasrasaria R, Jonas JB, Kan H, Kanis JA, Kassenbaum N, Kawakami N, Khang Y-H, Khatibzadeh S, Khoo J-P, Kok C, Laden F, Lalloo R, Lan Q, Lathlean T, Leasher JL, Leigh J, Li Y, Lin JK, Lipshultz SE, London S, Lozano R, Lu Y, Mak J, Malekzadeh R, Mallinger L, Marcenes W, March L, Marks RE, Martin RE, McGale P, McGrath J, Mehta S, Mensah GA, Merriman TR, Micha R, Michaud C, Mishra V, Hanafiah KM, Mokdad AA, Morawska L, Mozaffarian D, Murphy T, Naghavi M, Neal B, Nelson PK, Nolla JM, Norman R, Olives C, Omer SB, Orchard J, Osborne RH, Ostro B, Page A, Pandey KD, Parry CD, Passmore E, Patra J, Pearce N, Pelizarri PM, Petzold M, Phillips MR, Pope D, Pope CA III, Powles J, Rao M, Razavi H, Rehfuess EA, Rehm JT, Ritz B, Rivara FP, Roberts T, Robinson C, Rodriguez-Portales JA, Romieu I, Room R, Rosenfeld LC, Roy A, Rushton L, Salomon JA, Sampson U, Sanchez-Riera L, Sanman E, Sapkota A, Seedat S, Shi P, Shield KD, Shivakoti R, Singh GM, Sleet DA, Smith E, Smith KR, Stapelberg NJ, Steenland K, Stöckl H, Stovner P, Straif K, Straney L, Thurston GD, Tran JH, Dingenen RV, Van Donkelaar A, Lennert Veerman J, Vijayakumar L, Weintraub R, Weissman MM, White RA, Whiteford H, Wiersma ST, Wilkinson JD, Williams HC, Williams W, WIlson N, Woolf AD, Yip P, Zielinski JM, Lopez AD, Murray CL, Ezzati M (2012) A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 380:2224-2260.
88. Liu Y, Colditz GA, Rosner B, Berkey CS, Collins LC, Schnitt SJ, Connolly JL, Chen WDY, Willett WC, Tamimi RM (2013) Alcohol intake between menarche and first pregnancy: a prospective study of breast cancer risk. J Natl Cancer Inst 105:1571-1578.
89. Longnecker MP, Berlin JA, Orza MJ, Chalmers TC (1988) A meta-analysis of alcohol consumption in relation to risk of breast cancer. JAMA 260:652-656.
90. Longnecker MP, Newcomb PA, Mittendorf R, Greenberg ER, Clapp RW, Bogdan GF, Baron J, MacMahon B, Willett WC (1995) Risk of breast cancer in relation to lifetime alcohol consumption. J Natl Cancer Inst 87:923-929.
91. McCormack VA, Boffetta P (2011) Today's lifestyles, tomorrow's cancers: trends in lifestyle risk factors for cancer in low- and middle-income countries. Ann Oncol 22:2349-2357.
92. McGregor SE, Courneya KS, Kopciuk KA, Tosevski C, Friedenreich CM (2013) Case-control study of lifetime alcohol intake and prostate cancer risk. Cancer Causes Control 24:451-461.
93. McPherson K, Steel C, Dixon JM (2000) Breast cancer-epidemiology, risk factors, and genetics. BMJ 321:624-628.
94. Mendelson KG, Contois LR, Tevosian SG, Davis RJ, Paulson KE (1996) Independent regulation of JNK/p38 mitogen-activated protein kinases by metabolic oxidative stress in the liver. Proc Natl Acad Sci USA 93:12908-12913.
95. Moher D, Liberati A, Tetzlaff J, Altman DG, The Prisma Group (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 6:e1000097.
96. Møller P, Wallin H (1998) Adduct formation, mutagenesis and nucleotide excision repair of DNA damage produced by reactive oxygen species and lipid peroxidation product. Mutat Res Rev Mutat Res 410:271-290.
97. Mørch LS, Johansen D, Thygesen LC, Tjønneland A, Løkkegaard E, Stahlberg C, Grønbæk M (2007) Alcohol drinking, consumption patterns and breast cancer among Danish nurses: a cohort study. Eur J Public Health 17:624-629.
98. Morgan MJ, Liu ZG (2011) Crosstalk of reactive oxygen species and NF-κB signaling. Cell Res 21:103-115.
99. Murray CJL, Ezzati M, Lopez A, Rodgers A, Vander Hoorn S (2003) Comparative quantification of health risks conceptual framework and methodological issues. Popul Health Metr 1:1-20.
100. National Cancer Institute (2002) Red Wine and Cancer Prevention. National Cancer Institute Fact Sheet 4.25. Publication number: F119. National Cancer Institute, Rockville, MD.
101. Nelson DE, Jarman DW, Rehm J, Greenfield TK, Rey G, Kerr WC, Miller P, Shield KD, Ye Y, Naimi TS (2013) Alcohol-attributable cancer deaths and years of potential life lost in the United States. Am J Public Health 103:641-648.
102. Ng ST, Zhou J, Adesanya OO, Wang J, Leroith D, Bondy CA (1997) Growth hormone treatment induces mammary gland hyperplasia in aging primates. Nat Med 3:1141-1144.
103. Page S, Powell D, Benboubetra M, Stevens CR, Blake DR, Selase F, Wolstenholme AJ, Harrison R (1998) Xanthine oxidoreductase in human mammary epithelial cells: activation in response to inflammatory cytokines. Biochim Biophys Acta 1381:191-202.
104. Parry C, Patra J, Rehm J (2011) Alcohol consumption and non-communicable diseases: epidemiology and policy implications. Addiction 106:1718-1724.
105. Praud D, Rota M, Rehm J, Shield K, Zatonski W, Hashibe M, La Vecchia C, Boffetta P (2016) Cancer incidence and mortality attributable to alcohol consumption. Int J Cancer 138:1380-1387.
106. Rehm J (2015) Light or moderate drinking is linked to alcohol related cancers, including breast cancer. BMJ 351:h4400.
107. Rehm J, Ashley MJ, Room R, Single E, Bondy S, Ferrence R, Giesbrecht N (1996) On the emerging paradigm of drinking patterns and their social and health consequences. Addiction 91:1615-1621.
108. Rehm J, Baliunas D, Borges GL, Graham K, Irving HM, Kehoe T, Parry CD, Patra J, Popova L, Poznyak V, Roerecke M, Room R, Samokhvalov AV, Taylor B (2010a) The relation between different dimensions of alcohol consumption and burden of disease-an overview. Addiction 105:817-843.
109. Rehm J, Kehoe T, Gmel G, Stinson F, Grant B, Gmel G (2010b) Statistical modeling of volume of alcohol exposure for epidemiological studies of population health: the example of the US. Popul Health Metr 8:3.
110. Rehm J, Mathers C, Popova S, Thavorncharoensap M, Teerawattananon Y, Patra J (2009) Global burden of disease and injury and economic cost attributable to alcohol use and alcohol use disorders. Lancet 373:2223-2233.
111. Rintala J, Jaatinen P, Parkkila S, Sarviharju M, Kiianmaa K, Hervonen A, Niemelä O (2000) Evidence of acetaldehyde-protein adduct formation in rat brain after lifelong consumption of ethanol. Alcohol Alcohol 35:458-462.
112. Rojdmark S, Rydvald Y, Aquilonius A, Brismar K (2000) Insulin-like growth factor (IGF)-1 and IGF-binding protein-1 concentrations in serum of normal subjects after alcohol ingestion: evidence for decreased IGF-1 bioavailability. Clin Endocrinol 52:313-318.
113. Ronis MJJ, Lindros KO, Ingelman-Sundberg M (1996) The cytochromeP4502E subfamily, in Cytochromes P450, Pharmacological and Toxicological Aspects (Ioannides I ed), pp 221-239. CRC Press, Boca Raton, FL.
114. Russo IH, Russo J (1996) Mammary gland neoplasia in long-term rodent studies. Environ Health Perspect 104:938-967.
115. Rutter CM, Mandelson MT, Laya MB, Taplin S (2001) Changes in breast density associated with initiation, discontinuation, and continuing use of hormone replacement therapy. JAMA 285:171-176.
116. Santolaria F, González-González G, González-Reimers G, Martínez-Riera A, Milena A, Rodgíguez-Moreno F, González-García C (1995) Effects of alcohol and liver cirrhosis on the GF-IGF-I axis. Alcohol Alcohol 30:703-708.
117. Secretan B, Straif K, Baan R, Grosse Y, El Ghissassi F, Bouvard V, Benbrahim-Tallaa L, Guha N, Freeman C, Galichet L, Cogliano V; WHO International Agency for Research on Cancer Monograph Working Group (2009) A review of human carcinogens-Part E: tobacco, areca nut, alcohol, coal smoke, and salted fish. Lancet Oncol 10:1033-1034.
118. Seitz HK, Pelucchi C, Bagnardi V, La Vecchia C (2012) Epidemiology and pathophysiology of alcohol and breast cancer: update 2012. Alcohol Alcohol 47:204-212.
119. Seitz HK, Stickel F (2007) Molecular mechanisms of alcohol-mediated carcinogenesis. Nat Rev Cancer 7:599-612.
120. Sellers TA, Vierkant RA, Cerhan JR, Gapstur SM, Vachon CM, Olson JE, Pankratz VS, Kushi LH, Folsom AR (2002) Interaction of dietary folate intake, alcohol, and risk of hormone receptor-defined breast cancer in a prospective study of postmenopausal women. Cancer Epidemiol Biomark Prev 11:1104-1107.
121. Shield K, Rehm M, Patra J, Sornpaisarn B, Rehm J (2011) Global and country specific adult per capita consumption of alcohol, 2008. Sucht 57:99-117.
122. Shield KD, Parry C, Rehm J (2013) Chronic diseases and conditions related to alcohol use. Alcohol Res 35:155-171.
123. Shinohara M, Adachi Y, Mitsushita J, Kuwabara M, Nagasawa A, Harada S, Furuta S, Zhang Y, Seheli K, Miyazaki H, Kamata T (2010) Reactive oxygen generated by NADPH oxidase 1 (Nox1) contributes to cell invasion by regulating matrix metalloprotease-9 production and cell migration. J Biol Chem 285:4481-4488.
124. Siemann EH, Creasy LL (1992) Concentration of the phytoalexin resveratrol in wine. Am J Enol Vitic 43:49-52.
125. Singletary KW, Frey RS, Yan W (2001) Effect of ethanol on proliferation and estrogen receptor-α expression in human breast cancer cells. Cancer Lett 165:131-137.
126. Sinha D, Sarkar N, Biswas J, Bishayee A (2016) Resveratrol for breast cancer prevention and therapy: preclinical evidence and molecular mechanisms. Semin Cancer Biol doi: 10.1016/j.semcancer.2015.11.001 [Epub ahead of print].
127. Soerjomataram I, Pukkala E, Brenner H, Coebergh JWW (2008) On the avoidability of breast cancer in industrialized societies: older mean age at first birth as an indicator of excess breast cancer risk. Breast Cancer Res Treat 111:297-302.
128. Stockwell T, Greer A, Fillmore K, Chikritzhs T, Zeisser C (2012) How good is the science. BMJ 344:e2276.
129. Suga S, Kato K, Ohgami T, Yamayoshi A, Adachi S, Asanoma K, Yamaguchi S, Arima T, Kinoshita K, Wake N (2007) An inhibitory effect on cell proliferation by blockage of the MAPK/estrogen receptor/MDM2 signal pathway in gynecologic cancer. Gynecol Oncol 105:341-350.
130. Suzuki R, Orsini N, Mignone L, Saji S, Wolk A (2008) Alcohol intake and risk of breast cancer defined by estrogen and progesterone receptor status. A meta-analysis of epidemiological studies. Int J Cancer 122:1832-1841.
131. Terry MB, Gammon MD, Zhang FF, Knight JA, Wang Q, Britton JA, Teitelbaum SL, Neugut AI, Santella RM (2006) ADH3 genotype, alcohol intake and breast cancer risk. Carcinogenesis 27:840-847.
132. Thygesen LC, Mørch LS, Keiding N, Johansen C, Grønbæk M (2008) Use of baseline and updated information on alcohol intake on risk for breast cancer: importance of latency. Int J Epidemiol 37:669-677.
133. Tjønneland A, Christensen J, Olsen A, Stripp C, Thomsen BL, Overvad K, Peeters PH, van Gils CH, Bueno-de-Mesquita HB, Ocke MC, Thiebaut A, Fournier A, Clavel-Chapelon F, Berrino F, Palli D, Tumino R, Panico S, Vineis P, Agudo A, Ardanaz E, Martinez-Garcia C, Amiano P, Navarro C, Quiros JR, Key TJ, Reeves G, Khaw KT, Bingham S, Trichopoulou A, Trichopoulos D, Naska A, Nagel G, Chang-Claude J, Boeing H, Lahmann PH, Manjer J, Wirfalt E, Hallmans G, Johansson I, Lund E, Skeie G, Hjartaker A, Ferrari P, Slimani N, Kaaks R, Riboli E (2007) Alcohol intake and breast cancer risk: the European Prospective Investigation into Cancer and Nutrition (EPIC). Cancer Causes Control 18:361-373.
134. Torres-Mejía G, Royer R, Llacuachaqui M, Akbari MR, Giuliano AR, Martínez-Matsushita L, Angeles-Llerenas A, Ziv E, Lazcano-Ponce E, Phelan CM, Narod SA (2015) Recurrent BRCA1 and BRCA2 mutations in Mexican women with breast cancer. Cancer Epidemiol Biomark Prev 24:495-505.
135. United Nations (2013) World Population Prospects: The 2012 Revision. United Nations, New York, NY.
136. Vaca CE, Nilsson JA, Fang JL, Grafstrom RC (1998) Formation of DNA adducts in human buccal epithelial cells exposed to acetaldehyde and methylglyoxal in vitro. Chem Biol Interact 108:197-208.
137. Vachon CM, Kushi LH, Cerhan JR, Kuni CC, Sellers TA (2000) Association of diet and mammographic breast density in the Minnesota breast cancer family cohort. Cancer Epidemiol Biomark Prev 9:151-160.
138. Valko M, Rhodes CJ, Moncol J, Izakovic MM, Mazur M (2006) Free radicals, metals and antioxidants in oxidative stress-induced cancer. Chem Biol Interact 160:1-40.
139. Varela-Rey M, Woodhoo A, Martinez-Chantar ML, Mato JM, Lu SC (2013) Alcohol, DNA methylation, and cancer. Alcohol Res 35:25-35.
140. van't Veer P, Sturmans F, Hermus RJJ, Kok FJ (1989) Alcohol dose, frequency and age at first exposure in relation to the risk of breast cancer. Int J Epidemiol 18:511-517.
141. Visvanathan K, Crum RM, Strickland PT, You X, Ruczinski I, Berndt SI, Alberg AJ, Hoffman SC, Comstock GW, Bell DA, Helzlsouer KJ (2007) Alcohol dehydrogenase genetic polymorphisms, low-to-moderate alcohol consumption and risk of breast cancer. Alcohol Clin Exp Res 31:467-476.
142. Wang XD (2005) Alcohol, vitamin A, and cancer. Alcohol 35:251-258.
143. World Cancer Research Fund International, American Institute for Cancer Research (2014) Continuous Update Project Report: Diet, Nutrition, Physical Activity, and Breast Cancer Survivors. World Cancer Research Fund International, American Institute for Cancer Research, London, UK.
144. World Health Organization (2014) Global Status Report on Alcohol and Health. World Health Organization, Geneva, Switzerland.
145. World Health Organization (2015) Global Information System on Alcohol and Health. World Health Organization, Geneva, Switzerland.
146. Wright RM, McManaman JL, Repine JE (1999) Alcohol-induced breast cancer: a proposed mechanism. Free Radic Biol Med 26:348-354.
147. Wu WS (2006) The signaling mechanism of ROS in tumor progression. Cancer Metastasis Rev 25:695-705.
148. Yablonski-Peretz T, Paluch-Shimon S, Gutman LS, Kaplan Y, Dvir A, Barnes-Kedar I, Kadouri L, Semenisty V, Efrat N, Neiman V, Glasser Y, Michaelson-Cohen R, Katz L, Kaufman B, Golan T, Reish O, Hubert A, Safra T, Yaron Y, Friedman E (2016) Screening for germline mutations in breast/ovarian cancer susceptibility genes in high-risk families in Israel. Breast Cancer Res Treat 155:133-138.
149. Young TB (1989) A case-control study of breast cancer and alcohol consumption habits. Cancer 64:552-558.
150. Yu H, Berkel H (1999) Do insulin-like growth factors mediate the effect of alcohol on breast cancer risk? Med Hypotheses 52:491-496.
151. Zakhari S, Hoek JB (2015) Alcohol and breast cancer: reconciling epidemiological and molecular data. Adv Exp Med Biol 815:7-39.
152. Zeisser C, Stockwell TR, Chikritzhs T (2014) Methodological biases in estimating the relationship between alcohol consumption and breast cancer: the role of drinker misclassification errors in meta-analytic results. Alcohol Clin Exp Res 38:2297-2306.
153. Zhang S, Hunter DJ, Hankinson SE, Giovannucci EL, Rosner BA, Colditz GA, Speizer FE, Willett WC (1999) A prospective study of folate intake and the risk of breast cancer. JAMA 281:1632-1637.
154. Zhang SM, Lee IM, Manson JE, Cook NR, Willett WC, Buring JE (2007) Alcohol consumption and breast cancer risk in the Women's Health Study. Am J Epidemiol 165:667-676.